Chemoinformaics analysis of Rivularin (flavone)
| Molecular Weight | 344.319 | nRot | 4 |
| Heavy Atom Molecular Weight | 328.191 | nRig | 18 |
| Exact Molecular Weight | 344.09 | nRing | 3 |
| Solubility: LogS | -3.85 | nHRing | 1 |
| Solubility: LogP | 3.072 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 17 |
| nHA | 7 | APOL | 46.3427 |
| nHD | 2 | BPOL | 23.8633 |
| QED | 0.751 |
| Synth | 2.509 |
| Natural Product Likeliness | 1.328 |
| NR-PPAR-gamma | 0.944 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.522 |
| Pgp-sub | 0.003 |
| HIA | 0.051 |
| CACO-2 | -4.857 |
| MDCK | 0.0000195 |
| BBB | 0.011 |
| PPB | 0.851602 |
| VDSS | 0.724 |
| FU | 0.177226 |
| CYP1A2-inh | 0.906 |
| CYP1A2-sub | 0.966 |
| CYP2c19-inh | 0.344 |
| CYP2c19-sub | 0.198 |
| CYP2c9-inh | 0.731 |
| CYP2c9-sub | 0.88 |
| CYP2d6-inh | 0.299 |
| CYP2d6-sub | 0.869 |
| CYP3a4-inh | 0.535 |
| CYP3a4-sub | 0.343 |
| CL | 5.178 |
| T12 | 0.425 |
| hERG | 0.098 |
| Ames | 0.586 |
| ROA | 0.161 |
| SkinSen | 0.09 |
| Carcinogencity | 0.063 |
| EI | 0.471 |
| Respiratory | 0.199 |
| NR-Aromatase | 0.877 |
| Antiviral | Yes |
| Prediction | 0.850383 |